Catalyst Pharmaceuticals Inc (CPRX)
16.57
+0.11 (+0.67%)
USD |
NASDAQ |
Mar 31, 16:00
16.58
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Enterprise Value: 1.441B for March 30, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| March 30, 2023 | 1.441B |
| March 29, 2023 | 1.468B |
| March 28, 2023 | 1.431B |
| March 27, 2023 | 1.439B |
| March 24, 2023 | 1.405B |
| March 23, 2023 | 1.394B |
| March 22, 2023 | 1.414B |
| March 21, 2023 | 1.448B |
| March 20, 2023 | 1.434B |
| March 17, 2023 | 1.384B |
| March 16, 2023 | 1.366B |
| March 15, 2023 | 1.217B |
| March 14, 2023 | 1.271B |
| March 13, 2023 | 1.247B |
| March 10, 2023 | 1.243B |
| March 09, 2023 | 1.286B |
| March 08, 2023 | 1.316B |
| March 07, 2023 | 1.296B |
| March 06, 2023 | 1.291B |
| March 03, 2023 | 1.328B |
| March 02, 2023 | 1.312B |
| March 01, 2023 | 1.329B |
| February 28, 2023 | 1.308B |
| February 27, 2023 | 1.321B |
| February 24, 2023 | 1.308B |
| Date | Value |
|---|---|
| February 23, 2023 | 1.310B |
| February 22, 2023 | 1.321B |
| February 21, 2023 | 1.307B |
| February 17, 2023 | 1.335B |
| February 16, 2023 | 1.303B |
| February 15, 2023 | 1.318B |
| February 14, 2023 | 1.329B |
| February 13, 2023 | 1.337B |
| February 10, 2023 | 1.330B |
| February 09, 2023 | 1.331B |
| February 08, 2023 | 1.312B |
| February 07, 2023 | 1.408B |
| February 06, 2023 | 1.372B |
| February 03, 2023 | 1.396B |
| February 02, 2023 | 1.365B |
| February 01, 2023 | 1.313B |
| January 31, 2023 | 1.332B |
| January 30, 2023 | 1.356B |
| January 27, 2023 | 1.335B |
| January 26, 2023 | 1.385B |
| January 25, 2023 | 1.463B |
| January 24, 2023 | 1.398B |
| January 23, 2023 | 1.255B |
| January 20, 2023 | 1.891B |
| January 19, 2023 | 1.835B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
137.65M
Minimum
Dec 24 2018
1.917B
Maximum
Jan 13 2023
494.95M
Average
375.09M
Median
Enterprise Value Benchmarks
| Ardelyx Inc | 850.60M |
| Jaguar Health Inc | 37.18M |
| Avalo Therapeutics Inc | 29.34M |
| Avenue Therapeutics Inc | 5.867M |
| Cosmos Health Inc | 48.81M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 25.47M |
| Revenue (Quarterly) | 60.76M |
| Total Expenses (Quarterly) | 29.96M |
| EPS Diluted (Quarterly) | 0.22 |
| Gross Profit Margin (Quarterly) | 81.57% |
| Profit Margin (Quarterly) | 41.92% |
| Earnings Yield | 4.46% |
| Operating Earnings Yield | 5.53% |
| Normalized Earnings Yield | 4.465 |